Does Icon PLC (ICLR) benefit from R&D spending?
Parnassus Investmentsthe investment management company has released its 2025 investor letter for the first quarter of the “Parnassus Mid Cap Growth Fund.” A copy of a letter can do so I downloaded it from here. The Russell Midcap Growth Index fell 7.12% in the first quarter, starting with the continuation of the rally in late 2024, but later fell sharply. The fund (investment stock) fell by -9.98% (net fees) in the quarter, compared to a -7.12% decline in the Russell Midcap Growth Index. Consumer discretion and industry stock selection contributed to relative performance, but communication services and healthcare were undermined. Plus, check out our top 5 holdings funds to find out the best picks of 2025.
In its first quarter, 2025 investor letter, Parnassus Mid Cap Growth Fund announced the Icon Public Limited Company (NASDAQ:ICLR). Headquartered in Dublin, Ireland, Icon Public Limited Company (NASDAQ: ICLR) is a clinical research organization. The one-month return of Icon Public Limited Company (NASDAQ: ICLR) was 8.03%, and its shares have lost 52.57% of its value in the past 52 weeks. On July 2, 2025, Icon Public Limited Company (NASDAQ: ICLR) stock closed at $150.82 per share, with a market capitalization of $1198.8 billion.
The Parnassus Mid Cap Growth Fund said in its 2025 Investor Letter from ICON Public Limited Company (NASDAQ: ICLR):
“Icon Public Limited Company (NASDAQ: ICLR) is the second largest player in the clinical research institution (CRO) market due to its size and competitive advantages created by its long-standing customer relationships. After being sold after delayed R&D spending in the biotech industry, we bought the stock. Stock trading is undervalued for cyclical declines in revenue, so I think Icon will benefit as R&D spending improves and the company continues to gain market share. ”
Laboratory setup with a team of scientists working on clinical trials.
Icon Public Limited Company (NASDAQ: ICLR) is not listed 30 Most Popular Stocks of Hedge Funds. According to the database, the 44 hedge fund portfolio held the ICON Public Limited Company (NASDAQ: ICLR) at the end of the first quarter, when he was 46 years old in the last quarter. Icon Public Limited Company (NASDAQ: ICLR) 1st quarter Revenue It fell 4.3% year-on-year to $2 billion. While we acknowledge the potential of Icon Public Limited Company (NASDAQ: ICLR) as an investment, our belief lies in the belief that AI stocks provide higher returns and hold a greater promise to do so within a shorter time frame. If you’re looking for AI stocks that are as promising as Nvidia, but traded at less than five times the revenues, Undervalued AI Stocks for Large Profits.